Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study.
[BACKGROUND] Although observational studies have suggested an association between male infertility and prostate cancer (PCa) risk, the causal relationship has not been established.
- p-value P = 0.011
- OR 1.0044
APA
Shao J, Apizi A, et al. (2025). Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study.. European journal of medical research, 31(1), 21. https://doi.org/10.1186/s40001-025-03461-y
MLA
Shao J, et al.. "Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study.." European journal of medical research, vol. 31, no. 1, 2025, pp. 21.
PMID
41327353
Abstract
[BACKGROUND] Although observational studies have suggested an association between male infertility and prostate cancer (PCa) risk, the causal relationship has not been established.
[METHODS] We conducted a bidirectional two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) summary data to investigate the causal relationship between male infertility and PCa. The primary analysis was performed using the inverse variance weighted (IVW) method, supplemented by three additional MR approaches. We systematically evaluated the heterogeneity and pleiotropy of the instrumental variables and employed linkage disequilibrium score regression (LDSC) to assess the genetic correlation between the two conditions. Furthermore, we incorporated factors such as obesity and prostatitis into a multivariable Mendelian randomization framework. Additionally, within the bidirectional MR framework, we explored the causal association between the expression of the PCa biomarker prostate-specific antigen (PSA) and male infertility. Finally, we employed a summary data-based Mendelian randomization (SMR) analysis to identify genes potentially involved in the pathogenesis of PCa. We then performed a preliminary analysis of the differential expression of these significant candidate genes between normal and cancerous tissues using publicly available databases.
[RESULTS] Based on the fundamental principles of MR, six instrumental variables for male infertility were selected for analysis with PCa. All four analytical methods (primarily the IVW method, OR = 1.0044, 95% CI = 0.9824-1.0269, P = 0.697) consistently indicated the absence of a causal association. Reverse MR analysis suggested no significant causal relationship (IVW, OR = 0.9769, 95% CI = 0.85-1.1123, P = 0.724). Sensitivity analyses, including heterogeneity tests (Cochran's Q), pleiotropy assessment (MR-Egger intercept), and leave-one-out validation, confirmed the robustness of these findings. Furthermore, LDSC indicated no significant genetic correlation between male infertility and PCa (Rg = - 0.1102, P = 0.494). After excluding the influence of other exposure factors, multivariable Mendelian randomization results suggested an independent causal effect of prostatitis on PCa risk (IVW, OR = 1.093, 95% CI = 1.0206-1.1707, P = 0.011). No significant causal association was demonstrated between PSA and male infertility (IVW, OR = 0.981, 95% CI = 0.8055-1.1942, P = 0.847).
[CONCLUSION] Our findings provide no evidence for a causal relationship between male infertility and PCa in either direction.
[METHODS] We conducted a bidirectional two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) summary data to investigate the causal relationship between male infertility and PCa. The primary analysis was performed using the inverse variance weighted (IVW) method, supplemented by three additional MR approaches. We systematically evaluated the heterogeneity and pleiotropy of the instrumental variables and employed linkage disequilibrium score regression (LDSC) to assess the genetic correlation between the two conditions. Furthermore, we incorporated factors such as obesity and prostatitis into a multivariable Mendelian randomization framework. Additionally, within the bidirectional MR framework, we explored the causal association between the expression of the PCa biomarker prostate-specific antigen (PSA) and male infertility. Finally, we employed a summary data-based Mendelian randomization (SMR) analysis to identify genes potentially involved in the pathogenesis of PCa. We then performed a preliminary analysis of the differential expression of these significant candidate genes between normal and cancerous tissues using publicly available databases.
[RESULTS] Based on the fundamental principles of MR, six instrumental variables for male infertility were selected for analysis with PCa. All four analytical methods (primarily the IVW method, OR = 1.0044, 95% CI = 0.9824-1.0269, P = 0.697) consistently indicated the absence of a causal association. Reverse MR analysis suggested no significant causal relationship (IVW, OR = 0.9769, 95% CI = 0.85-1.1123, P = 0.724). Sensitivity analyses, including heterogeneity tests (Cochran's Q), pleiotropy assessment (MR-Egger intercept), and leave-one-out validation, confirmed the robustness of these findings. Furthermore, LDSC indicated no significant genetic correlation between male infertility and PCa (Rg = - 0.1102, P = 0.494). After excluding the influence of other exposure factors, multivariable Mendelian randomization results suggested an independent causal effect of prostatitis on PCa risk (IVW, OR = 1.093, 95% CI = 1.0206-1.1707, P = 0.011). No significant causal association was demonstrated between PSA and male infertility (IVW, OR = 0.981, 95% CI = 0.8055-1.1942, P = 0.847).
[CONCLUSION] Our findings provide no evidence for a causal relationship between male infertility and PCa in either direction.
MeSH Terms
Male; Humans; Prostatic Neoplasms; Mendelian Randomization Analysis; Infertility, Male; Genome-Wide Association Study; Risk Factors; Polymorphism, Single Nucleotide; Genetic Predisposition to Disease
같은 제1저자의 인용 많은 논문 (5)
- The role of WNT10B expression in the prognosis of colorectal cancer: A retrospective study based on TCGA database and clinical data.
- The Role of CD4 T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy.
- Patient preference for first-line treatments of ALK-positive metastatic non-small cell lung cancer: a discrete choice experiment.
- Structured skin care for a patient with toxic epidermal necrolysis caused by anlotinib: Case report.
- Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation.